Showing 1261-1270 of 1717 results for "".
Status Migrainosus
https://practicalneurology.com/diseases-diagnoses/headache-pain/status-migrainosus/31902/Outpatient management of status migrainosus is possible and often preferable.Movement Disorders Moment: Treatment Approaches to Cervical Dystonia
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-treatment-approaches-to-cervical-dystonia/31720/Botulinum toxins are effective treatment.Discontinuing Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapies-in-multiple-sclerosis/31875/Over the course of multiple sclerosis, there may come a point where the risks of disease-modifying therapies outweigh the benefits.Spinal Muscular Atrophy is Now a Treatable Genetic Condition
https://practicalneurology.com/diseases-diagnoses/neuromuscular/spinal-muscular-atrophy-is-now-a-treatable-genetic-condition/32025/Multiple therapy options are available for the treatment of people with spinal muscular atrophy, a genetic disorder presenting with a wide range of symptoms and severity.Catamenial Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/catamenial-epilepsy/31944/Understanding the underlying hormone pathophysiology and types of catamenial epilepsy is necessary for determining treatment options.Rehabilitation for People with Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rehabilitation-for-people-with-movement-disorders/32043/There are 2 main objectives to neurologic rehabilitation for people with movement disorders: 1) to maintain body structure and 2) to maximize functional skills.Digital Biomarkers in Neuromuscular Disorders: Recent Advances
https://practicalneurology.com/diseases-diagnoses/neuromuscular/digital-biomarkers-in-neuromuscular-disorders-recent-advances/35556/Digital health technologies have strong potential to aid in the study and management of neuromuscular conditions.Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis/31814/More treatments for myasthenia gravis are on the way.Emerging Therapies to Slow the Progression of Huntington Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/emerging-therapies-to-slow-the-progression-of-huntington-disease/31936/Although clinical trial results have been disappointing, they have moved development of potential disease-modifying treatments forward.